^
    2years
    B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, The First People's Hospital of Lianyungang
    New P1 trial • CAR T-Cell Therapy
    |
    CD276 (CD276 Molecule)
    |
    cyclophosphamide • fludarabine IV • KT095